Recently, a microfluidics device has been built to generate a chemical gradient resulting in nine different concentrations of galactose (or other small molecules) to induce different α-synuclein levels in a yeast PD model, but no inclusions were observed by galactose administration alone (Fernandes et al., 2014). This evidence concerns the gene SNCA and Parkinson disease.